Table 1 Characteristics of clinic universal screening participants screened for probable OUD and co-occurring depression and/or PTSD
Characteristic | N (%) or Median (Q1, Q3) |
|---|---|
Sample Size | 1145 |
Age in years, Median (Q1, Q3) | 50 (33, 62) |
Gender, n (%) | |
Female | 747 (65.2%) |
Male | 377 (32.9%) |
Transgender | 10 (0.9%) |
Did not identify as Male, Female, or Transgender | 3 (0.3%) |
Did not respond | 8 (0.7%) |
Took survey in Spanish, n (%) | 122 (10.7%) |
Positive for probable opioid use disorder (myTAPS), n (%) | 51 (4.5%) |
PHQ-8 score (n = 1108a) | |
Median (Q1, Q3) | 1.0 (0.0, 2.0) |
Mean (SD) | 3.7 (6.2) |
Positive for probable depression (PHQ-8 ≥ 10), n (%) | 200 (17.5%) |
PC-PTSD-5 Score (n = 465a,b) | |
Median (Q1, Q3) | 2.0 (1.0, 4.0) |
Mean (SD) | 2.4 (1.9) |
Positive for probable post-traumatic stress disorder (PC-PTSD-5 ≥ 3), n (%) | 218 (19.0%) |
Positive for depression & post-traumatic stress disorder, n (%) | 102 (8.9%) |
Positive for probable opioid use disorder + depression and/or post-traumatic stress disorder, n (%) | 27 (2.4%) |
Positive for probable opioid use disorder + depression + post-traumatic stress disorder, n (%) | 10 (0.9%) |
Often have pain, n (%) | 598 (52.2%) |
Pain severity, n (%) | |
Mild | 107 (17.9%) |
Moderate | 336 (56.2%) |
Severe | 151 (25.3%) |
Did not respond | 4 (0.7%) |
Length of time with pain, n (%) | |
< 1 week | 32 (5.4%) |
1 week—2 months | 52 (8.7%) |
2–6 months | 52 (8.7%) |
> 6 months | 415 (69.4%) |
Don’t know | 41 (6.9%) |
Did not respond | 6 (1.0%) |